cimetidine has been researched along with Ache in 79 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of oral cimetidine as a treatment for painful bladder disease (PBD, variously described as a 'symptom complex' of suprapubic pain, frequency, dysuria and nocturia in the absence of overt urine infection) by assessing symptom relief and histological changes in the bladder wall tissue components, compared with placebo." | 9.09 | Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. ( Thilagarajah, R; Walker, MM; Witherow, RO, 2001) |
| "An open-controlled trial performed in gastric ulcer cases resistant to previous cimetidine, antacids, vitamin A and polyvinylbutylether therapy applied for at least 4 weeks." | 9.06 | Successful treatment of intractable gastric ulcers with acetazolamide. ( Erdei, A; Gedeon, A; Gyóri, I; Szabó, I, 1990) |
| "We randomly assigned 159 patients with non-ulcer dyspepsia, defined as chronic or recurrent epigastric pain without concomitant symptoms of the irritable bowel syndrome and with no evidence of organic disease, to treatment for three weeks with an antacid suspension one and three hours after meals, 400 mg of cimetidine twice a day, or placebo, according to a double-blind, double-dummy model." | 9.06 | Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. ( Adami, HO; Bates, S; Bergström, R; Gustavsson, S; Lööf, L; Nyberg, A; Nyrén, O, 1986) |
| "We conducted a double-blind, randomized, parallel group study in 169 patients with acute duodenal ulcers to compare omeprazole, 20 mg daily, with cimetidine, 600 mg twice daily." | 9.06 | Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. ( Archambault, AP; Bailey, RJ; Baker, SJ; Freeman, HJ; Hunt, RH; Marcon, NE; Navert, H; Pare, P; Sutherland, L; Williams, CN, 1988) |
| "In this double-blind, parallel-group multicenter study, patients with endoscopically proven gastric ulcers were randomly allocated to treatment with either 50 micrograms or 200 micrograms of misoprostol or 300 mg of cimetidine, each given four times daily for four weeks." | 9.06 | A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients. ( Chapman, JW; Nicholson, PA; Rachmilewitz, D, 1986) |
| "The efficacy of famotidine, a potent new long-acting H2 receptor antagonist, was compared with cimetidine in 78 patients with endoscopically proven acute duodenal ulcers." | 9.06 | Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine. ( Fölsch, UR; Hartmann, H, 1988) |
| "In a multicenter, single-blind, randomized trial, the effectiveness in pain relief and healing of three regimens of H2-receptor antagonists was compared in 338 patients with endoscopically confirmed active duodenal ulcers, 112 receiving cimetidine 300 mg four times daily (QID), 110 receiving cimetidine 800 mg at bedtime (HS), and 116 receiving ranitidine 300 mg HS." | 9.06 | An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease. ( Lottes, SR; Webb, LA; Young, MD, 1988) |
| "This multicentre, double-blind study evaluated the efficacy of cimetidine 800 mg nocte compared to placebo for ulcer healing and pain relief in patients with endoscopically confirmed, benign gastric ulcers treated for up to 8 weeks." | 9.06 | Acute treatment of benign gastric ulcer with once-daily bedtime dosing of cimetidine compared with placebo. ( Frank, WO; Karlstadt, R; Mounce, W; O'Connell, S; Palmer, R; Rockhold, F; Young, MD, 1989) |
| "A randomized double-blind antacid-controlled study was carried out to investigate the speed of onset of relief from dyspeptic pain with a novel, chewable formulation of cimetidine in 80 patients with persistent dyspepsia." | 9.06 | Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief? ( Parr, SN, 1989) |
| "Famotidine (40 mg) and 800 mg cimetidine as single night-time doses were compared in a randomized, double-blind, multicentre study of acute treatment for duodenal ulceration." | 9.06 | Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer. ( Booth, SN; Cochran, KM; Cottrell, J; Crowe, J; Dickinson, RJ; Kennedy, NP; Lee, FI; Mann, SG, 1989) |
| "We conducted a 12-week, double-blind, randomized, placebo-controlled trial to determine whether cimetidine (300 mg with meals and at bedtime) or a convenient, liquid aluminum-magnesium antacid regimen (15 ml one hour after meals and at bedtime) would expedite healing or relief of symptoms in patients with benign gastric ulcer." | 9.05 | Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial. ( Anderson, DS; Elashoff, JD; Frankl, H; Ippoliti, AF; Isenberg, JI; Longstreth, GF; Peterson, WL; Reedy, TJ; Sandersfeld, MA; Van Deventer, GM, 1983) |
| "We conducted a double-blind randomized study of 132 patients to determine whether the new, investigational proton-pump inhibitor, omeprazole (30 mg per day), would accelerate healing and pain relief, as compared with cimetidine (1 g per day), in patients with duodenal ulcer." | 9.05 | Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. ( Andersen, HH; Bendtsen, F; Bytzer, P; Højlund, M; Jensen, KG; Kelbaek, H; Lauritsen, K; Linde, J; Rask-Madsen, J; Rune, SJ, 1985) |
| "Colloidal bismuth subcitrate (CBS, DE-NOL) and cimetidine have been compared in a double-blind randomized trial in the management of 75 patients with duodenal ulcer." | 9.05 | Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. ( Hollanders, D; Martin, DF; Miller, JP; Ravenscroft, MM; Tweedle, DE, 1982) |
| "We studied the healing efficacy of cimetidine or placebo in 23 endoscopically proven duodenal ulcer outpatients in a randomized, controlled, prospective, double-blind trial." | 9.05 | Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy. ( Arguello, JF; Collen, MJ; Gardner, L; Hanan, MR; Maher, JA; Rent, M; Stubrin, SE, 1980) |
| "A randomized, double-blind, double-dummy comparative 6-week study of tri-potassium di-citrato bismuthate (TDB) (Ulcerone; De-Nol) chewing tables and cimetidine was carried out in 60 patients suffering from duodenal ulceration." | 9.05 | Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study. ( Khan, F; Moshal, MG; Spitaels, JM, 1981) |
| "Seventy-one patients with duodenal ulcer disease completed a 3- to 6-week controlled randomized trial in which cimetidine (1 g daily) was compared with an optimally effective dose of propantheline." | 9.05 | Cimetidine or propantheline combined with antacid therapy for short-term treatment of duodenal ulcer. ( Adami, HO; Björklund, O; Enander, LK; Gustavsson, S; Lööf, L; Nordahl, A; Rosén, A, 1982) |
| "Cimetidine therapy in gastric ulcer disease has been evaluated in four complete and one incomplete controlled, double blind trials." | 9.04 | Cimetidine in the treatment of gastric ulcer: review and commentary. ( Freston, JW, 1978) |
| "In a controlled double-blind clinical trial of 39 in-patients with gastric ulcer the effect of cimetidine on ulcer healing, ulcer pain and pentagastrin-stimulated acid and pepsin secretion was measured." | 9.04 | [In-patient treatment of peptic ulcer with cimetidine. II. Controlled double-blind trial on gastric ulcer patients (author's transl)]. ( Albinus, M; Dölle, W; Horn, B; Malchow, H; Schomerus, H; Sewing, KF, 1978) |
| "To determine whether oral cimetidine, which reportedly improves symptoms in 60-70% of patients with painful bladder syndrome/interstitial cystitis has a similar mechanism of action on the human bladder and involving a similar peptidergic pathway as it has in human stomach, where it alters histamine-gastrin reactions mediated via H2 receptors and a proton pump." | 7.71 | Cimetidine in painful bladder syndrome: a histopathological study. ( Blackford, HN; Dasgupta, P; Dennis, P; Sharma, SD; Womack, C, 2001) |
| "Cimetidine was administered to two patients for herpes zoster infection." | 7.67 | Effect of cimetidine on herpes zoster infection. ( Bense, L; Marcusson, JA; Ramsten, T, 1987) |
| "To evaluate the efficacy of oral cimetidine as a treatment for painful bladder disease (PBD, variously described as a 'symptom complex' of suprapubic pain, frequency, dysuria and nocturia in the absence of overt urine infection) by assessing symptom relief and histological changes in the bladder wall tissue components, compared with placebo." | 5.09 | Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. ( Thilagarajah, R; Walker, MM; Witherow, RO, 2001) |
| "We randomly assigned 159 patients with non-ulcer dyspepsia, defined as chronic or recurrent epigastric pain without concomitant symptoms of the irritable bowel syndrome and with no evidence of organic disease, to treatment for three weeks with an antacid suspension one and three hours after meals, 400 mg of cimetidine twice a day, or placebo, according to a double-blind, double-dummy model." | 5.06 | Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. ( Adami, HO; Bates, S; Bergström, R; Gustavsson, S; Lööf, L; Nyberg, A; Nyrén, O, 1986) |
| "A large dose validation study compared cimetidine 800 mg at bedtime, a dose known to provide maximum acid suppression through the night, with placebo, cimetidine 400 mg, and 1,600 mg in the treatment of acute duodenal ulcer." | 5.06 | Dose validation and study design criteria in current cimetidine studies. ( Braverman, AJ, 1986) |
| "An open-controlled trial performed in gastric ulcer cases resistant to previous cimetidine, antacids, vitamin A and polyvinylbutylether therapy applied for at least 4 weeks." | 5.06 | Successful treatment of intractable gastric ulcers with acetazolamide. ( Erdei, A; Gedeon, A; Gyóri, I; Szabó, I, 1990) |
| "Endoscopic evidence of accelerated healing of type I gastric ulcers after four weeks of omeprazole." | 5.06 | Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group. ( , 1989) |
| "Famotidine (40 mg) and 800 mg cimetidine as single night-time doses were compared in a randomized, double-blind, multicentre study of acute treatment for duodenal ulceration." | 5.06 | Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer. ( Booth, SN; Cochran, KM; Cottrell, J; Crowe, J; Dickinson, RJ; Kennedy, NP; Lee, FI; Mann, SG, 1989) |
| "This multicentre, double-blind study evaluated the efficacy of cimetidine 800 mg nocte compared to placebo for ulcer healing and pain relief in patients with endoscopically confirmed, benign gastric ulcers treated for up to 8 weeks." | 5.06 | Acute treatment of benign gastric ulcer with once-daily bedtime dosing of cimetidine compared with placebo. ( Frank, WO; Karlstadt, R; Mounce, W; O'Connell, S; Palmer, R; Rockhold, F; Young, MD, 1989) |
| "A randomized double-blind antacid-controlled study was carried out to investigate the speed of onset of relief from dyspeptic pain with a novel, chewable formulation of cimetidine in 80 patients with persistent dyspepsia." | 5.06 | Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief? ( Parr, SN, 1989) |
| "In a multicenter, single-blind, randomized trial, the effectiveness in pain relief and healing of three regimens of H2-receptor antagonists was compared in 338 patients with endoscopically confirmed active duodenal ulcers, 112 receiving cimetidine 300 mg four times daily (QID), 110 receiving cimetidine 800 mg at bedtime (HS), and 116 receiving ranitidine 300 mg HS." | 5.06 | An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease. ( Lottes, SR; Webb, LA; Young, MD, 1988) |
| "The efficacy of famotidine, a potent new long-acting H2 receptor antagonist, was compared with cimetidine in 78 patients with endoscopically proven acute duodenal ulcers." | 5.06 | Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine. ( Fölsch, UR; Hartmann, H, 1988) |
| "In this double-blind, parallel-group multicenter study, patients with endoscopically proven gastric ulcers were randomly allocated to treatment with either 50 micrograms or 200 micrograms of misoprostol or 300 mg of cimetidine, each given four times daily for four weeks." | 5.06 | A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients. ( Chapman, JW; Nicholson, PA; Rachmilewitz, D, 1986) |
| "The purpose of this study was to determine if pirenzepine and cimetidine given together was superior to cimetidine alone in inducing healing of refractory duodenal ulcers which remained unhealed after treatment with cimetidine or ranitidine for at least eight weeks." | 5.06 | Combined anti-muscarinic and H2 receptor blockade in the healing of refractory duodenal ulcer. A double blind study. ( Bardhan, KD; Bose, K; Crowe, J; Hinchliffe, RF; McCarthy, C; Thompson, M; Thompson, MH; Thomson, TJ; Walters, J; Weir, DG, 1987) |
| "We conducted a double-blind, randomized, parallel group study in 169 patients with acute duodenal ulcers to compare omeprazole, 20 mg daily, with cimetidine, 600 mg twice daily." | 5.06 | Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. ( Archambault, AP; Bailey, RJ; Baker, SJ; Freeman, HJ; Hunt, RH; Marcon, NE; Navert, H; Pare, P; Sutherland, L; Williams, CN, 1988) |
| "Colloidal bismuth subcitrate (CBS, DE-NOL) and cimetidine have been compared in a double-blind randomized trial in the management of 75 patients with duodenal ulcer." | 5.05 | Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. ( Hollanders, D; Martin, DF; Miller, JP; Ravenscroft, MM; Tweedle, DE, 1982) |
| "We studied the healing efficacy of cimetidine or placebo in 23 endoscopically proven duodenal ulcer outpatients in a randomized, controlled, prospective, double-blind trial." | 5.05 | Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy. ( Arguello, JF; Collen, MJ; Gardner, L; Hanan, MR; Maher, JA; Rent, M; Stubrin, SE, 1980) |
| "We conducted a 12-week, double-blind, randomized, placebo-controlled trial to determine whether cimetidine (300 mg with meals and at bedtime) or a convenient, liquid aluminum-magnesium antacid regimen (15 ml one hour after meals and at bedtime) would expedite healing or relief of symptoms in patients with benign gastric ulcer." | 5.05 | Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial. ( Anderson, DS; Elashoff, JD; Frankl, H; Ippoliti, AF; Isenberg, JI; Longstreth, GF; Peterson, WL; Reedy, TJ; Sandersfeld, MA; Van Deventer, GM, 1983) |
| "Seventy-one patients with duodenal ulcer disease completed a 3- to 6-week controlled randomized trial in which cimetidine (1 g daily) was compared with an optimally effective dose of propantheline." | 5.05 | Cimetidine or propantheline combined with antacid therapy for short-term treatment of duodenal ulcer. ( Adami, HO; Björklund, O; Enander, LK; Gustavsson, S; Lööf, L; Nordahl, A; Rosén, A, 1982) |
| "A randomized, double-blind, double-dummy comparative 6-week study of tri-potassium di-citrato bismuthate (TDB) (Ulcerone; De-Nol) chewing tables and cimetidine was carried out in 60 patients suffering from duodenal ulceration." | 5.05 | Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study. ( Khan, F; Moshal, MG; Spitaels, JM, 1981) |
| "We conducted a double-blind randomized study of 132 patients to determine whether the new, investigational proton-pump inhibitor, omeprazole (30 mg per day), would accelerate healing and pain relief, as compared with cimetidine (1 g per day), in patients with duodenal ulcer." | 5.05 | Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. ( Andersen, HH; Bendtsen, F; Bytzer, P; Højlund, M; Jensen, KG; Kelbaek, H; Lauritsen, K; Linde, J; Rask-Madsen, J; Rune, SJ, 1985) |
| "In a controlled double-blind clinical trial of 39 in-patients with gastric ulcer the effect of cimetidine on ulcer healing, ulcer pain and pentagastrin-stimulated acid and pepsin secretion was measured." | 5.04 | [In-patient treatment of peptic ulcer with cimetidine. II. Controlled double-blind trial on gastric ulcer patients (author's transl)]. ( Albinus, M; Dölle, W; Horn, B; Malchow, H; Schomerus, H; Sewing, KF, 1978) |
| "Cimetidine therapy in gastric ulcer disease has been evaluated in four complete and one incomplete controlled, double blind trials." | 5.04 | Cimetidine in the treatment of gastric ulcer: review and commentary. ( Freston, JW, 1978) |
| "To determine whether oral cimetidine, which reportedly improves symptoms in 60-70% of patients with painful bladder syndrome/interstitial cystitis has a similar mechanism of action on the human bladder and involving a similar peptidergic pathway as it has in human stomach, where it alters histamine-gastrin reactions mediated via H2 receptors and a proton pump." | 3.71 | Cimetidine in painful bladder syndrome: a histopathological study. ( Blackford, HN; Dasgupta, P; Dennis, P; Sharma, SD; Womack, C, 2001) |
| "Because previous studies have suggested that activation of baroreceptors could mediate stress-induced analgesia, the effect of acute exposure to footshock on mean arterial pressure (MAP) and pain sensitivity was simultaneously determined in conscious rats receiving the histamine H2 receptor antagonist cimetidine or vehicle." | 3.67 | Cimetidine-sensitive analgesia: investigation of the importance of stress-induced changes in arterial pressure. ( Hough, LB; Licata, SP; Werber, AH, 1988) |
| "Cimetidine was administered to two patients for herpes zoster infection." | 3.67 | Effect of cimetidine on herpes zoster infection. ( Bense, L; Marcusson, JA; Ramsten, T, 1987) |
| "Therapeutic measures for acute pancreatitis depend on the severity of the disease and its complications." | 2.37 | Acute and chronic pancreatitis. An update on management. ( Lankisch, PG, 1984) |
| "Cholestasis was induced by ligation of the main bile duct using two ligatures and transsection of the duct at the midpoint between them." | 1.37 | Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats. ( Hasanein, P, 2011) |
| " Because a) the mechanism of action of improgan remains unknown and b) this drug may indirectly activate cannabinoid CB(1) receptors, the effects of the CB(1) antagonist/inverse agonist rimonabant (SR141716A) and 3 congeners with varying CB(1) potencies were studied on improgan antinociception after intracerebroventricular (icv) dosing in rats." | 1.34 | Significance of cannabinoid CB1 receptors in improgan antinociception. ( Abood, ME; Gehani, NC; Hough, LB; Martin, BR; Nalwalk, JW; Razdan, RK; Sun, X; Wentland, M, 2007) |
| ") dosing in rats, six of eight drugs produced dose- and time-related antinociception on both the tail flick and hot plate tests over a nearly eight-fold range of potencies." | 1.33 | Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic. ( Hough, LB; Lu, Q; Montero, MJ; Nalwalk, JW; Shan, Z; Svokos, K; Wentland, MP, 2005) |
| "Pain was predominant in the hip area, disappeared within a few days after withdrawal and recurred three weeks after resuming therapy." | 1.27 | Recurrent myalgias associated with cimetidine. ( Cabanne, JF; Dubot, P; Labeeuw, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 55 (69.62) | 18.7374 |
| 1990's | 4 (5.06) | 18.2507 |
| 2000's | 16 (20.25) | 29.6817 |
| 2010's | 4 (5.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Altenbach, RJ | 1 |
| Carr, TL | 1 |
| Chandran, P | 1 |
| Hsieh, GC | 1 |
| Lewis, LG | 1 |
| Manelli, AM | 1 |
| Milicic, I | 1 |
| Marsh, KC | 1 |
| Miller, TR | 1 |
| Strakhova, MI | 1 |
| Vortherms, TA | 1 |
| Wakefield, BD | 1 |
| Wetter, JM | 1 |
| Witte, DG | 1 |
| Honore, P | 1 |
| Esbenshade, TA | 1 |
| Brioni, JD | 1 |
| Cowart, MD | 1 |
| Boyo, A | 1 |
| McKay, J | 1 |
| Lebovic, G | 1 |
| Psutka, DJ | 1 |
| Hough, LB | 10 |
| Svokos, K | 4 |
| Nalwalk, JW | 8 |
| Sea, J | 1 |
| Teichman, JM | 1 |
| Hasanein, P | 1 |
| Stadel, R | 2 |
| Carpenter, AB | 1 |
| de Esch, IJ | 1 |
| Janssen, E | 1 |
| Heinricher, MM | 1 |
| Martenson, ME | 1 |
| Timmerman, H | 1 |
| Leurs, R | 2 |
| Paria, BC | 1 |
| Wang, X | 1 |
| Dey, SK | 1 |
| Ashmawi, HA | 1 |
| Chambergo, FS | 1 |
| Araújo Palmeira, CC | 1 |
| Posso, IP | 1 |
| Timmermann, H | 1 |
| Tincello, DG | 1 |
| Walker, AC | 1 |
| Lu, Q | 1 |
| Shan, Z | 1 |
| Wentland, MP | 1 |
| Montero, MJ | 1 |
| Gehani, NC | 1 |
| Razdan, RK | 1 |
| Martin, BR | 1 |
| Sun, X | 1 |
| Wentland, M | 1 |
| Abood, ME | 1 |
| Liu, T | 1 |
| Bai, ZT | 1 |
| Pang, XY | 1 |
| Chai, ZF | 1 |
| Jiang, F | 1 |
| Ji, YH | 1 |
| Lankisch, PG | 1 |
| Heading, RC | 1 |
| Baker, JP | 1 |
| Richelson, E | 1 |
| Stabile, BE | 1 |
| Passaro, E | 1 |
| Isenberg, JI | 1 |
| Peterson, WL | 1 |
| Elashoff, JD | 1 |
| Sandersfeld, MA | 1 |
| Reedy, TJ | 1 |
| Ippoliti, AF | 1 |
| Van Deventer, GM | 1 |
| Frankl, H | 1 |
| Longstreth, GF | 1 |
| Anderson, DS | 1 |
| Strum, WB | 1 |
| Tishler, M | 1 |
| Abramov, A | 1 |
| Habs, M | 1 |
| Glaser, E | 1 |
| Döpfer, H | 1 |
| Rufín, F | 1 |
| Llorens, P | 1 |
| Altschiller, H | 1 |
| Miranda, M | 1 |
| Shandera, R | 1 |
| Gotthard, R | 1 |
| Ström, M | 1 |
| Bodemar, G | 1 |
| Walan, A | 1 |
| Tytgat, GN | 1 |
| van Bentem, N | 1 |
| van Olffen, G | 1 |
| Dekker, W | 1 |
| Rutgeerts, L | 1 |
| de Boer, J | 1 |
| Miller, JP | 1 |
| Hollanders, D | 1 |
| Ravenscroft, MM | 1 |
| Tweedle, DE | 1 |
| Martin, DF | 1 |
| Sorkin, EM | 1 |
| Ogawa, GS | 1 |
| Goodlin, R | 1 |
| Woods, R | 1 |
| Williams, N | 1 |
| Rune, SJ | 2 |
| Møllman, KM | 1 |
| Rahbek, I | 1 |
| Brunner, H | 1 |
| Collen, MJ | 1 |
| Hanan, MR | 1 |
| Maher, JA | 1 |
| Rent, M | 1 |
| Stubrin, SE | 1 |
| Arguello, JF | 1 |
| Gardner, L | 1 |
| Bright-Asare, P | 1 |
| El-Bassoussi, M | 1 |
| Moshal, MG | 1 |
| Spitaels, JM | 1 |
| Khan, F | 1 |
| Adami, HO | 3 |
| Björklund, O | 1 |
| Enander, LK | 1 |
| Gustavsson, S | 3 |
| Lööf, L | 3 |
| Nordahl, A | 1 |
| Rosén, A | 1 |
| Bernaldo de Quirós González, J | 1 |
| Reverte Cejudo, D | 1 |
| Galilea Bazaco, I | 1 |
| Fernández Rubio, E | 1 |
| Shanahan, F | 1 |
| Crowe, J | 3 |
| Lewi, H | 1 |
| Thilagarajah, R | 1 |
| Witherow, RO | 1 |
| Walker, MM | 1 |
| Parada, CA | 1 |
| Tambeli, CH | 1 |
| Cunha, FQ | 1 |
| Ferreira, SH | 1 |
| Dasgupta, P | 1 |
| Sharma, SD | 1 |
| Womack, C | 1 |
| Blackford, HN | 1 |
| Dennis, P | 1 |
| Redstone, HA | 1 |
| Barrowman, N | 1 |
| Veldhuyzen Van Zanten, SJ | 1 |
| Haq, A | 1 |
| Donaldson, PJ | 1 |
| Parry, JR | 1 |
| Morris, T | 1 |
| Rhodes, J | 1 |
| Powell-Jackson, P | 1 |
| Barkley, H | 1 |
| Northfield, TC | 1 |
| Sewing, KF | 1 |
| Malchow, H | 1 |
| Albinus, M | 1 |
| Horn, B | 1 |
| Schomerus, H | 1 |
| Dölle, W | 1 |
| Misiewicz, JJ | 1 |
| Freston, JW | 1 |
| Corbett, CL | 1 |
| Holdsworth, CD | 1 |
| Krowicki, ZK | 1 |
| Erdei, A | 1 |
| Gyóri, I | 1 |
| Gedeon, A | 1 |
| Szabó, I | 1 |
| Farup, PG | 1 |
| Weberg, R | 1 |
| Berstad, A | 1 |
| Wetterhus, S | 1 |
| Dahlberg, O | 1 |
| Dybdahl, J | 1 |
| Fyllingen, G | 1 |
| Kannelønning, KS | 1 |
| Lange, OJ | 1 |
| Nyberg, A | 2 |
| Nyrén, O | 2 |
| Klimczak, J | 1 |
| Lee, FI | 1 |
| Booth, SN | 1 |
| Cochran, KM | 1 |
| Dickinson, RJ | 1 |
| Kennedy, NP | 1 |
| Cottrell, J | 1 |
| Mann, SG | 1 |
| Frank, WO | 1 |
| Young, MD | 2 |
| Palmer, R | 1 |
| Rockhold, F | 1 |
| Karlstadt, R | 1 |
| Mounce, W | 1 |
| O'Connell, S | 1 |
| Parr, SN | 1 |
| Lottes, SR | 1 |
| Webb, LA | 1 |
| Glick, SD | 1 |
| Su, K | 1 |
| Hartmann, H | 1 |
| Fölsch, UR | 1 |
| Rachmilewitz, D | 1 |
| Chapman, JW | 1 |
| Nicholson, PA | 1 |
| Bardhan, KD | 1 |
| Thompson, M | 1 |
| Bose, K | 1 |
| Hinchliffe, RF | 1 |
| Weir, DG | 1 |
| McCarthy, C | 1 |
| Walters, J | 1 |
| Thomson, TJ | 1 |
| Thompson, MH | 1 |
| Brint-Nielsen, P | 1 |
| Christiansen, LV | 1 |
| Damsbo, N | 1 |
| Nørrelund, N | 1 |
| Archambault, AP | 1 |
| Pare, P | 1 |
| Bailey, RJ | 1 |
| Navert, H | 1 |
| Williams, CN | 1 |
| Freeman, HJ | 1 |
| Baker, SJ | 1 |
| Marcon, NE | 1 |
| Hunt, RH | 1 |
| Sutherland, L | 1 |
| Licata, SP | 1 |
| Werber, AH | 1 |
| Bense, L | 1 |
| Marcusson, JA | 1 |
| Ramsten, T | 1 |
| Bates, S | 1 |
| Bergström, R | 1 |
| Villagrasa Serrano, M | 1 |
| Arenas Miravé, JI | 1 |
| Berenguer Lapuerta, J | 1 |
| Gallego, E | 1 |
| García Plaza, A | 1 |
| Herrerías Gutiérrez, JM | 1 |
| Roca García, M | 1 |
| Rodrigo Sáez, L | 1 |
| Rodrigo Moreno, M | 1 |
| Sainz Samitier, R | 1 |
| Braverman, AJ | 1 |
| Gallagher, CG | 1 |
| Lennon, JR | 1 |
| Crowe, JP | 1 |
| Labeeuw, M | 1 |
| Cabanne, JF | 1 |
| Dubot, P | 1 |
| Lauritsen, K | 1 |
| Bytzer, P | 1 |
| Kelbaek, H | 1 |
| Jensen, KG | 1 |
| Rask-Madsen, J | 1 |
| Bendtsen, F | 1 |
| Linde, J | 1 |
| Højlund, M | 1 |
| Andersen, HH | 1 |
| Spiro, HM | 1 |
| Lewis, JH | 1 |
| Davies, J | 1 |
| Collins, AJ | 1 |
| Dixon, SA | 1 |
6 reviews available for cimetidine and Ache
| Article | Year |
|---|---|
Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.
Topics: Administration, Intravesical; Amitriptyline; Child; Cimetidine; Cystitis, Interstitial; Diet Therapy | 2009 |
Acute and chronic pancreatitis. An update on management.
Topics: Acute Disease; Animals; Aprotinin; Chronic Disease; Cimetidine; Dogs; Enzyme Inhibitors; Enzyme Ther | 1984 |
The use of tricyclic antidepressants in chronic gastrointestinal pain.
Topics: Abdomen; Antidepressive Agents, Tricyclic; Chronic Disease; Cimetidine; Doxepin; Humans; Pain; Pepti | 1982 |
H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.
Topics: Cimetidine; Dyspepsia; Histamine H2 Antagonists; Humans; Pain; Randomized Controlled Trials as Topic | 2001 |
Antacids and peptic ulcer--a reappraisal.
Topics: Aluminum Hydroxide; Antacids; Calcium Carbonate; Cimetidine; Clinical Trials as Topic; Double-Blind | 1979 |
Peptic ulceration and its correlation with symptoms.
Topics: Carbenoxolone; Chronic Disease; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Duodenum; Endo | 1978 |
35 trials available for cimetidine and Ache
| Article | Year |
|---|---|
Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Antacids; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Guanidines | 1983 |
Treatment of active prepyloric and duodenal ulcers with antacid/anticholinergic, cimetidine and placebo.
Topics: Adult; Aluminum Hydroxide; Antacids; Atropine; Cimetidine; Clinical Trials as Topic; Double-Blind Me | 1982 |
Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blin | 1982 |
Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; | 1982 |
Pirenzepine and cimetidine in the treatment of peptic ulcer.
Topics: Anti-Ulcer Agents; Benzodiazepinones; Cimetidine; Drug Therapy, Combination; Female; Guanidines; Hum | 1982 |
Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy.
Topics: Administration, Oral; Adult; Aged; Analgesics; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; | 1980 |
Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Gastroesophageal Reflux; G | 1980 |
Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study.
Topics: Adult; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; G | 1981 |
Cimetidine or propantheline combined with antacid therapy for short-term treatment of duodenal ulcer.
Topics: Adult; Aged; Antacids; Cimetidine; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulc | 1982 |
Cimetidine in treatment of interstitial cystitis.
Topics: Cimetidine; Cystitis; Humans; Pain | 1995 |
Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Analgesics, Non-Narcotic; Biopsy; Cimetidine; Double-Blind Method | 2001 |
Antacids and peptic ulcer--a reappraisal.
Topics: Aluminum Hydroxide; Antacids; Calcium Carbonate; Cimetidine; Clinical Trials as Topic; Double-Blind | 1979 |
Effect of cimetidine in symptomatic gastro-oesophageal reflux.
Topics: Adult; Aged; Antacids; Cimetidine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combinat | 1978 |
[In-patient treatment of peptic ulcer with cimetidine. II. Controlled double-blind trial on gastric ulcer patients (author's transl)].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Gastric Acidity Dete | 1978 |
Peptic ulceration and its correlation with symptoms.
Topics: Carbenoxolone; Chronic Disease; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Duodenum; Endo | 1978 |
Cimetidine in the treatment of gastric ulcer: review and commentary.
Topics: Antacids; Cimetidine; Guanidines; Hospitalization; Humans; Pain; Recurrence; Stomach Ulcer | 1978 |
Successful treatment of intractable gastric ulcers with acetazolamide.
Topics: Acetazolamide; Cimetidine; Humans; Pain; Prospective Studies; Stomach Ulcer | 1990 |
Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study.
Topics: Administration, Oral; Adult; Aged; Antacids; Cimetidine; Double-Blind Method; Drug Administration Sc | 1990 |
Symptomatic cimetidine treatment of duodenal and prepyloric ulcers.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Gastroscopy; Humans; Male; Midd | 1986 |
Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group.
Topics: Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1989 |
Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Cimetidine; Double-Blind M | 1989 |
Acute treatment of benign gastric ulcer with once-daily bedtime dosing of cimetidine compared with placebo.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1989 |
Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?
Topics: Administration, Oral; Adult; Aged; Antacids; Cimetidine; Double-Blind Method; Dyspepsia; Female; Hum | 1989 |
An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cimetidine; Drug Administration Schedule; Duodenal Ulcer | 1988 |
Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Me | 1988 |
A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.
Topics: Adolescent; Adult; Aged; Alprostadil; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Dose- | 1986 |
Combined anti-muscarinic and H2 receptor blockade in the healing of refractory duodenal ulcer. A double blind study.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; D | 1987 |
[Cimetidine in herpes zoster. A double-blind study in general practice].
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Herpes Zoster; Humans; Pain; Random Alloc | 1987 |
Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief.
Topics: Adult; Aged; Antacids; Cimetidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admin | 1988 |
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Topics: Adolescent; Adult; Antacids; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Met | 1986 |
[Cimetidine, single nocturnal doses in the treatment of duodenal ulcer].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Drug Administration Schedule; Duodenal Ulcer; Fem | 1986 |
Dose validation and study design criteria in current cimetidine studies.
Topics: Adolescent; Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female | 1986 |
Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial.
Topics: Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Clinical Trials as Topic; Double-Blind M | 1985 |
Summary of the 29th meeting of the Gastrointestinal Drugs Advisory Committee, Food and Drug Administration--June 10, 1985.
Topics: Abortion, Spontaneous; Animals; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blin | 1985 |
The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs.
Topics: Analgesics; Antacids; Anti-Inflammatory Agents; Arthritis; Cimetidine; Drug Evaluation; Drug Utiliza | 1986 |
40 other studies available for cimetidine and Ache
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; | 2008 |
Temporomandibular joint total replacement using the Zimmer Biomet Microfixation patient-matched prosthesis results in reduced pain and improved function.
Topics: Cimetidine; Humans; Joint Prosthesis; Pain; Prosthesis Design; Range of Motion, Articular; Retrospec | 2019 |
Non-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms.
Topics: Analgesics; Animals; Benzoxazines; Brain Stem; Cannabinoid Receptor Modulators; Cimetidine; Male; Mi | 2009 |
Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
Topics: Analgesia; Animals; Benzothiazoles; Cholestasis; Cimetidine; Dimaprit; Disease Models, Animal; Hista | 2011 |
Inhibition of brain [(3)H]cimetidine binding by improgan-like antinociceptive drugs.
Topics: Analgesics; Animals; Binding Sites; Brain; Cimetidine; Dose-Response Relationship, Drug; Histamine; | 2010 |
Neural basis for improgan antinociception.
Topics: Action Potentials; Analgesics, Non-Narcotic; Animals; Cimetidine; Injections, Intraventricular; Male | 2010 |
Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptor
Topics: Analgesics; Animals; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Ventricles; Cime | 2002 |
The effects of pyrilamine and cimetidine on mRNA C-fos expression and nociceptive flinching behavior in rats.
Topics: Animals; Behavior, Animal; Blotting, Northern; Cimetidine; Dose-Response Relationship, Drug; Formald | 2003 |
Pain-relieving drugs and the brain histaminergic system: multiple analgesic mechanisms from histamine, improgan and cimetidine.
Topics: Analgesics; Animals; Cimetidine; Male; Muscimol; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley | 2004 |
Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group.
Topics: Anticonvulsants; Cimetidine; Cystitis, Interstitial; Depression; Dimethyl Sulfoxide; Female; Histami | 2005 |
Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
Topics: Algorithms; Analgesics; Animals; Behavior, Animal; Benzothiazoles; Brain; Cimetidine; Dose-Response | 2005 |
Cannabinoid-improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor.
Topics: Analgesics; Analysis of Variance; Animals; Benzoxazines; Binding, Competitive; Cannabinoids; Cimetid | 2006 |
Significance of cannabinoid CB1 receptors in improgan antinociception.
Topics: Analgesics; Analysis of Variance; Animals; Cimetidine; Disease Models, Animal; Dose-Response Relatio | 2007 |
Degranulation of mast cells and histamine release involved in rat pain-related behaviors and edema induced by scorpion Buthus martensi Karch venom.
Topics: Animals; Chlorpheniramine; Cimetidine; Dose-Response Relationship, Drug; Edema; Histamine Antagonist | 2007 |
Antacids and duodenal ulcer.
Topics: Antacids; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Humans; Hydro | 1984 |
A new series of oral medications for chronic (cancer) pain relief.
Topics: Administration, Oral; Aluminum Hydroxide; Analgesics, Opioid; Antacids; Antiemetics; Cimetidine; Coc | 1984 |
Duodenal ulcer: a disease in evolution.
Topics: Adult; Aged; Aluminum; Antacids; Cimetidine; Duodenal Ulcer; Female; Gastrectomy; Humans; Male; Midd | 1984 |
Epigastric pain and HBP after biliary disease.
Topics: Abdomen; Biliary Tract Diseases; Cimetidine; Duodenal Ulcer; Erectile Dysfunction; Humans; Male; Mid | 1983 |
[Aminophyllin toxicity due to combined aminophyllin-cimetidine therapy].
Topics: Abdomen; Aged; Aminophylline; Cimetidine; Drug Interactions; Drug Therapy, Combination; Female; Huma | 1984 |
[The course of pain in patients with confirmed duodenal ulcer under therapy with cimetidine].
Topics: Adult; Cimetidine; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Pain; Time Factors | 1984 |
[Comparative study of 2 treatment schedules with cimetidine in patients with duodenal ulcer].
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; | 1983 |
Treatment of herpes zoster with cimetidine.
Topics: Aged; Cimetidine; Herpes Zoster; Humans; Pain | 1984 |
Antacids for duodenal ulcer.
Topics: Antacids; Cimetidine; Duodenal Ulcer; Humans; Pain | 1981 |
Cimetidine potentiation of narcotic action.
Topics: Adenocarcinoma; Aged; Cimetidine; Drug Synergism; Guanidines; Humans; Lung Neoplasms; Male; Methadon | 1983 |
Cimetidine and the epigastric pain of preeclampsia.
Topics: Cimetidine; Female; Guanidines; Humans; Pain; Pre-Eclampsia; Pregnancy; Stomach | 1983 |
Frequency of relapses in duodenal ulcer patients treated with cimetidine during symptomatic periods.
Topics: Cimetidine; Duodenal Ulcer; Female; Gastric Juice; Guanidines; Humans; Male; Pain; Prognosis; Recurr | 1980 |
[Clinical endoscopic, and secretory responses in patients with duodenal ulcer treated one gram per day of cimetidine for a year (author's transl)].
Topics: Adolescent; Adult; Cimetidine; Duodenal Ulcer; Female; Gastric Acid; Gastric Mucosa; Gastroscopy; Gu | 1981 |
Cimetidine and the control of pain in chronic relapsing pancreatitis.
Topics: Chronic Disease; Cimetidine; Guanidines; Humans; Pain; Pancreatitis; Recurrence | 1981 |
The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception.
Topics: Animals; Anti-Asthmatic Agents; Cimetidine; Cromolyn Sodium; Histamine; Histamine H1 Antagonists; Hi | 2001 |
Cimetidine in painful bladder syndrome: a histopathological study.
Topics: Cimetidine; Cystitis, Interstitial; Female; Follow-Up Studies; Histamine H2 Antagonists; Humans; Mal | 2001 |
Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Cimetidine; Double-Blind Method; Humans; Pain; Prosp | 2001 |
Fever, abdominal pain, and leucopenia during treatment with cimetidine.
Topics: Abdomen; Adult; Cimetidine; Female; Fever; Guanidines; Humans; Leukopenia; Pain; Transaminases | 1978 |
Cimetidine does not change the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
Topics: Amino Acid Sequence; Analysis of Variance; Animals; Chlorpheniramine; Cimetidine; Electroshock; Male | 1991 |
[Use of cimetidine with histamine in 4 patients with inoperable neoplasms of the upper part of the digestive tract].
Topics: Adenocarcinoma; Aged; Carcinoma; Cimetidine; Drug Therapy, Combination; Esophageal Neoplasms; Histam | 1985 |
A role for histamine and histamine H2-receptors in non-opiate footshock-induced analgesia.
Topics: Animals; Cimetidine; Electroshock; Haloperidol; Histamine; Histamine H2 Antagonists; Male; Naloxone; | 1985 |
Cimetidine-sensitive analgesia: investigation of the importance of stress-induced changes in arterial pressure.
Topics: Analgesia; Animals; Blood Pressure; Cimetidine; Electroshock; Foot; Male; Pain; Pain Measurement; Ra | 1988 |
Effect of cimetidine on herpes zoster infection.
Topics: Aged; Aged, 80 and over; Cimetidine; Female; Herpes Zoster; Humans; Male; Middle Aged; Pain | 1987 |
Chronic erosive gastritis: a clinical study.
Topics: Adolescent; Adult; Aged; Barium Sulfate; Chronic Disease; Cimetidine; Female; Follow-Up Studies; Gas | 1987 |
Recurrent myalgias associated with cimetidine.
Topics: Cimetidine; Duodenal Ulcer; Female; Humans; Middle Aged; Muscles; Nephritis, Interstitial; Pain; Rec | 1986 |
Duodenal ulcer disease.
Topics: Anti-Ulcer Agents; Benzimidazoles; Campylobacter Infections; Cimetidine; Duodenal Ulcer; Duodenoscop | 1985 |